Clinical Trials Browser

Recruiting × OTHER_GOV × 1 year × Clear all

NCT03536793 2026-03-18

TEM-PAC

Gastrointestinal

Pancreatic Cyst, Pancreatic Neoplasms

NCT05636514 2026-03-18

CELESTIAL-MDS

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT07477912 2026-03-17

MSTH-CAR001

Phase 1/2 Recruiting

Multiple Myeloma

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

Breast Neoplasms

NCT06990659 2026-03-11

CHOC

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Patient Satisfaction, Cholangiocarcinoma

NCT06704659 2026-03-09

RAY-no-BAN

Phase NA Recruiting

Breast Neoplasms, Recurrence

NCT05440838 2026-03-06

BioPredictor

Myeloproliferative Disorders

NCT06787183 2026-03-03

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer With Liver Metastases

NCT07445386 2026-03-03

Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain

Phase NA Recruiting

Gastrointestinal

Cancer Pain, Liver Neoplasms, Pancreatic Neoplasms, Abdominal Pain

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT07441785 2026-03-02

PROXISTAT

Gastrointestinal

Stomach Neoplasms

NCT06104371 2026-02-23

SentiNeo2

Breast Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Uterine Cervical Neoplasms

NCT06264167 2026-02-20

NODE

Phase NA Recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Phase NA Recruiting

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT06996483 2026-02-20

FUSION

Gastrointestinal

Depression, Gastrointestinal Neoplasms, Sleep Initiation and Maintenance Disorders

NCT07162675 2026-02-20

NEOBRE-STEP

Sleep Initiation and Maintenance Disorders, Motor Activity

NCT03997110 2026-02-17

RAPPAL

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT05875870 2026-02-17

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Phase NA Recruiting

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT04690972 2026-02-12

LivMOD

Gastrointestinal

Hepatitis D, Fibrosis, Hepatitis B, Hepatitis C, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT05954416 2026-02-12

FARD

Albinism, Ectodermal Dysplasia, Ichthyosis, Incontinentia Pigmenti, Keratoderma, Palmoplantar, Neurofibromatosis 1, Pemphigoid, Benign Mucous Membrane, Pemphigus

NCT07404176 2026-02-11

TENET

Phase 2 Recruiting

Neoplasms, Neuroendocrine Tumors

NCT07399535 2026-02-10

PCOS

Phase 1 Recruiting

Infertility, Metabolic Diseases, Polycystic Ovary Syndrome

NCT07196033 2026-02-09

AGBR-FERN-Gyn

Stage IIIA Cervical Cancer FIGO 2018

NCT05701527 2026-02-05

A Study of EBC-129 in Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT06804135 2026-02-04

STIRR

Uterine Cervical Neoplasms

NCT07179757 2026-02-04

Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.

Vulvo-vaginal Cancer

NCT07290972 2026-02-04

NCG-Compliance

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT07272616 2026-01-30

GDW

Brain Neoplasms

NCT07369921 2026-01-27

Pediatric Pilonidal Sinus Surgical Treatment

Phase NA Recruiting

Pilonidal Sinus

NCT07297433 2026-01-23

Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07211048 2026-01-21

Anti CD19 Gene Therapy for B-cell Lymphoma

Phase NA Recruiting

Lymphoma, B-Cell

NCT07349303 2026-01-21

NEOPRIME

Phase 2 Recruiting

Melanoma

NCT05264337 2026-01-16

Lymphedema After Urologic Surgery

Urinary Bladder Neoplasms, Lymphedema, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms

NCT07135466 2026-01-16

A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT06983639 2026-01-15

FIT

Phase NA Recruiting

Gastrointestinal

Polyps, Colorectal Neoplasms

NCT07338721 2026-01-15

Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?

Breast Neoplasms

NCT07342231 2026-01-15

FAP-1

Gastrointestinal

Pancreatic Neoplasms

NCT06032390 2026-01-14

AIMS Norway

Phase NA Recruiting

150,000 enrolled

Breast Neoplasms

NCT05345613 2026-01-13

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Phase 4 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT06117059 2026-01-12

PRECISION

Phase NA Recruiting

Prostatic Neoplasms

NCT06932172 2026-01-12

AI-DSSC

Phase NA Recruiting

Skin Neoplasms

NCT07050745 2026-01-12

DADA-LINK

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT07334431 2026-01-12

Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT06557343 2026-01-09

SPITFIRE

Neoplasms, Radiation Pneumonitis

NCT06967103 2026-01-08

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT07327021 2026-01-08

NOGA

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms